References
- Ellickson P. L., Bell R. M. Drug prevention in junior high: a multi‐site longitudinal test. Science 1990; 247: 1299–1305
- Chou S. P., Pickering R. P. Early onset of drinking as a risk factor for lifetime alcohol‐related problems. Br J Addict 1992; 87: 1199–1204
- Berman S. M., Noble E. P. Childhood antecedents of substance misuse. Curr Opin Psychiatry 1993; 6: 382–387
- Hawkins D. J., Catalano R. F., Miller J. Y. Risk and protective factors for alcohol and other drug problems in adolescence and early adulthood: implications for substance abuse prevention. Psychol Bull 1992; 112: 64–105
- Berman S. M., Whipple S. C., Fitch R. J., Noble E. P. P3 in young boys as a predictor of adolescent substance use. Alcohol 1993; 10: 69–76
- Peterson J. B., Finn P. R., Pihl R. O. Cognitive dysfunction and the inherited predisposition to alcoholism. J Stud Alcohol 1992; 53: 154–160
- Finn P. R., Earleywine M., Pihl R. O. Sensation seeking, stress reactivity, and alcohol dampening discriminate the density of a family history of alcoholism. Alcohol Oin Exp Res 1992; 16: 585–590
- Pogge D. L., Stokes I., Harvey P. D. Psychometric vs. attentional correlates of early onset alcohol and substance abuse. J Abnorm Child Psychol 1992; 20: 151–162
- Blum K., Noble E. P., Sheridan P. J., et al. Association of the Al allele of the D2 dopamine receptor gene with severe alcoholism. Alcohol 1991; 8: 409–416
- Klein R. G., Mannuzza S. Long‐term outcome of hyperactive children: a review. J Am Acad Child Adolesc Psychiatry 1991; 30: 383–387
- Kandel D. B., Yamaguchi K., Chen K. Stages of progression in drug involvement from adolescence to adulthood: further evidence for the gateway theory. J Stud Alcohol 1992; 53: 447–457
- Hammersley R., Lavelle T., Forsyth A. Predicting initiation to and cessation of buprenorphine and temazepam use amongst adolescents. Br J Addict 1992; 87: 1303–1311
- Blaze‐Temple D., Lo S. K. Stages of drug use: a community survey of Perth teenagers. Br J Addict 1992; 87: 215–225
- Kleber H. D. Epidemic cocaine abuse: America's present. Britain's future?. Br J Addict 1988; 83: 1359–1371
- Linszen D. H., Dingemans P. M., Lenior M. E. Cannabis abuse and the course of recent‐onset schizophrenic disorders. Arch Gen Psychiatry 1994; 51: 273–279
- Kosten T. A., Kosten T. R. Pharmacological blocking agents for treating substance abuse. J Nerv Ment Dis 1991; 179: 583–592
- Carroll K. M., Rounsaville B. J., Gordon L. T., et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry 1994; 51: 177–187
- Hartmann F., Poirier M. F., Bourdel M. C., Loo H., Lecomte J. M., Schwartz J. C. Comparison of acetorphan with clonidine for opiate withdrawal symptoms. Am J Psychiatry 1991; 148: 627–629
- Strain E. C., Stitzer M. L., Liebson L. A., Bigelow G. E. Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatry 1994; 151: 1025–1030
- Shufman E. N., Porat S., Witztum E., Gandacu D., Bar‐Hamburger R., Ginath Y. The efficacy of naltrexone in preventing reabuse of heroin after detoxication. Biol Psychiatry 1994; 35: 935–945
- Escriba P. V., Sastre M., Garcia‐Sevilla J. A. Increased density of guanine nucleotide‐binding proteins in the postmortem brains of heroin addicts. Arch Gen Psychiatry 1994; 51: 494–501
- Hyman S. E., Nestler E. J. The Molecular Foundations of Psychiatry. American Psychiatric Press, Washington 1993